Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Prostatic Neoplasms 17Prostate Cancer Metastatic 3Neoplasms 3Stomach Neoplasms 2Neoplasm Metastasis 2Carcinoma, Transitional Cell 2Urinary Bladder Neoplasms 1Small Cell Lung Carcinoma 1Recurrence 1Metastatic Breast Cancer With Intracranial Metastases 1Malignant Solid Tumor - Malignant Nervous System Neoplasm 1Lymphadenopathy 1Hormone-Resistant Prostate Cancer 1Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Oxaliplatin 53Cisplatin 52Fluorouracil 50Capecitabine 48pembrolizumab 39Leucovorin 31Docetaxel 26Trastuzumab 23Paclitaxel 20Irinotecan 20Ramucirumab 13Bevacizumab 12Cetuximab 9Radiotherapy 8Surgical Procedures, Operative 7S 1 (combination) 7Nivolumab 7Epirubicin 7Carboplatin 6olaparib 5Platinum 5Everolimus 5Sunitinib 4Mitomycin 4trastuzumab deruxtecan 3lenvatinib 3epacadostat 3bemarituzumab 3apatinib 3Saline Solution 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Stomach Neoplasms × cabazitaxel × Clear all
NCT01365130 2019-04-12

Chemotherapy for Patients With Gastroesophageal Cancers Who Have Progressed After One Prior Chemo Regimen

Brown University

Phase 2 Terminated
15 enrolled 8 charts
Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms

NCT01757171 2018-04-03

Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma

Weill Medical College of Cornell University

Phase 2 Completed
85 enrolled 11 charts
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡